MediWound (MDWD) Net Equity Issued and Repurchased (2014 - 2025)

MediWound's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $28.2 million for Q3 2025.

• In Q3 2025, Net Equity Issued and Repurchased rose 25.55% year-over-year to $28.2 million; the TTM figure through Sep 2025 stood at $50.6 million (up 5.77% YoY), while the FY2024 annual figure was $22.2 million, down 11.02% from the prior year.
• Net Equity Issued and Repurchased for Q3 2025 stood at $28.2 million, up from -$499000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $28.2 million in Q3 2025, with the low at -$556000.0 in Q2 2022.
• The 5-year median for Net Equity Issued and Repurchased is $10.4 million (2021), against an average of $10.6 million.
• The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased jumped 141.5% in 2023, then tumbled 98.02% in 2024.
• MediWound's Net Equity Issued and Repurchased stood at $10.4 million in 2021, then plunged by 105.34% to -$556000.0 in 2022, then jumped by 55.4% to -$248000.0 in 2023, then tumbled by 101.21% to -$499000.0 in 2024, then soared by 5745.09% to $28.2 million in 2025.
• Business Quant data shows MDWD's Net Equity Issued and Repurchased at $28.2 million in Q3 2025, -$499000.0 in Q4 2024, and $22.4 million in Q3 2024.